DK-AH 269

Suppliers

Names

[ CAS No. ]:
186097-54-1

[ Name ]:
DK-AH 269

[Synonym ]:
DK-AH 269
(S)-(+)-7,8-Dimethoxy-3-[[1-(2-(3,4-dimethoxyphenyl)ethyl)-3-piperidinyl]methyl]-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one hydrochloride
3-[[(3S)-1-[2-(3,4-dimethoxyphenyl)ethyl]piperidin-3-yl]methyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one,hydrochloride
DK-AH 269
Cilobradine (hydrochloride)

Chemical & Physical Properties

[ Boiling Point ]:
655.7ºC at 760 mmHg

[ Molecular Formula ]:
C28H39ClN2O5

[ Molecular Weight ]:
519.07300

[ Flash Point ]:
350.4ºC

[ Exact Mass ]:
518.25500

[ PSA ]:
60.47000

[ LogP ]:
4.28070

[ Vapour Pressure ]:
1.96E-17mmHg at 25°C

MSDS

Click to get detail MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

Articles

Use-dependent blockade of cardiac pacemaker current (If) by cilobradine and zatebradine.

Eur. J. Pharmacol. 478 , 161-171, (2003)

The action of the bradycardiac agents, cilobradine (DK-AH269) and zatebradine (UL-FS49), on the cardiac pacemaker current (If) was investigated on short Purkinje fibres from sheep hearts, using the tw...

Bradycardic and proarrhythmic properties of sinus node inhibitors.

Mol. Pharmacol. 69 , 1328-1337, (2006)

Sinus node inhibitors reduce the heart rate presumably by blocking the pacemaker current If in the cardiac conduction system. This pacemaker current is carried by four hyperpolarization-activated, cyc...

Use-dependent block of Ih in mouse dorsal root ganglion neurons by sinus node inhibitors.

Br. J. Pharmacol. 125 , 741-750, (1998)

1. The sinus node inhibitors UL FS 49 and DK-AH 269 reduce heart rate by slowing diastolic depolarization rate in the sino-atrial (SA) node, which might originate from the use-dependent blockade of a ...


More Articles

Related Compounds

  • DK-AH 268
  • 2-ah-cgmp sodium salt
  • 6-AH-CAMP
  • Akrilex AH
  • neocaesalpin AH
  • AQ-AH 208 hydrochloride
  • N-(2-((4-(2-fluorophenyl)piperazin-1-yl)sulfonyl)ethyl)-2-(trifluoromethyl)benzamide
  • 1-{[1-(4-fluorobenzenesulfonyl)-3,5-dimethyl-1H-pyrazol-4-yl]sulfonyl}piperidine
  • rac-[(1R,2R)-2-methylcyclobutyl]methanol
  • 1-((1-((4-chlorophenyl)sulfonyl)-3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl)azepane
  • 1-{[1-(4-methoxybenzenesulfonyl)-3,5-dimethyl-1H-pyrazol-4-yl]sulfonyl}piperidine
  • N-(2-((4-(2-fluorophenyl)piperazin-1-yl)sulfonyl)ethyl)-4-oxo-4H-chromene-2-carboxamide
  • 4-butoxy-N-(2-{[4-(4-fluorophenyl)piperazin-1-yl]sulfonyl}ethyl)benzamide
  • 2-(3,4-dimethoxyphenyl)-N-(2-{[4-(4-fluorophenyl)piperazin-1-yl]sulfonyl}ethyl)acetamide
  • 1-{[1-(4-tert-butylbenzenesulfonyl)-3,5-dimethyl-1H-pyrazol-4-yl]sulfonyl}-4-methylpiperidine
  • N-(2-((4-(4-fluorophenyl)piperazin-1-yl)sulfonyl)ethyl)-5-oxo-1-phenylpyrrolidine-3-carboxamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.